Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of a Family-Based Treatment for Preventing Anxiety Disorders in At-Risk Children
This study is currently recruiting participants.
Study NCT00847561   Information provided by National Institute of Mental Health (NIMH)
First Received: February 18, 2009   Last Updated: April 3, 2009   History of Changes

February 18, 2009
April 3, 2009
August 2008
August 2012   (final data collection date for primary outcome measure)
Anxiety Disorders Interview Schedule for DSM-IV (ADIS-IV) [ Time Frame: Measured pre- and post-treatment and after 6 and 12 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00847561 on ClinicalTrials.gov Archive Site
 
 
 
Effectiveness of a Family-Based Treatment for Preventing Anxiety Disorders in At-Risk Children
Family-Based Prevention for Childhood Anxiety

This study will test the effectiveness of a family-based behavioral program for preventing anxiety disorders in at-risk children.

Anxiety disorders are among the most common mental disorders in children and adolescents, and they are associated with short- and long-term impairment in social, academic, familial, and psychological functioning. The children of parents with anxiety disorders are more likely to develop anxiety disorders themselves, because of genetic factors and the atmosphere in which they are raised. Previous research indicates that the risk of anxiety disorders among children can be reduced through preventive therapy. In children with anxiety disorders whose parents also have anxiety disorders, therapy that includes their family is more successful than therapy focused only on the child. This study will test the effectiveness of a preventive, family-based therapy for children whose parents have anxiety disorders.

Participation in this study will last 1 year. First, participants will be asked to perform a screening assessment. This will include providing information about the symptoms, behaviors, and functioning of parent and child participants; filling out questionnaires; and videotaping the child and parent participants interacting. If, after the screening, participants are selected to continue with the study, they will be randomly assigned to receive either information monitoring or family-based cognitive behavioral therapy. Child and parent participants assigned to information monitoring will receive a booklet with information on coping with anxiety. Child and parent participants assigned to family-based cognitive behavioral therapy will meet with a study clinician for eight weekly 1-hour intervention visits, during which participants will learn skills to reduce anxiety. After completing the weekly visits, participants in this group will also receive three monthly booster sessions, in which coping skills will be reviewed. In addition to the screening visit, all participants will undergo identical assessments at three more time periods: 9 weeks after entering the study and 6 and 12 months after entering the study. All participants will also receive monthly phone calls throughout the study to monitor the children's anxiety symptoms.

 
Interventional
Prevention, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Anxiety Disorders
  • Behavioral: Brief family-based cognitive behavioral therapy
  • Behavioral: Information
  • Experimental: Participants will receive family-based cognitive behavioral therapy.
  • Placebo Comparator: Participants will receive information and monitoring.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
100
 
August 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Parents of child participant have an anxiety disorder

Exclusion Criteria:

  • Child has an anxiety disorder or is currently in treatment for anxiety
Both
7 Years to 12 Years
No
Contact: Golda S. Ginsburg, PhD 410-955-1544 gginsbu@jhmi.edu
Contact: Candice Festa, MS 443-287-4349
United States
 
NCT00847561
Golda S. Ginsburg, Johns Hopkins University School of Medicine
R01 MH077312, R01 MH077312-01, DDTR B4-TBI
National Institute of Mental Health (NIMH)
 
Principal Investigator: Golda S. Ginsburg, PhD Johns Hopkins University
National Institute of Mental Health (NIMH)
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP